MNX Stock Overview
Manitex Capital Inc. focuses on acquiring interests in life sciences, cleantech, and sustainable products/technologies companies.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Manitex Capital Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.17 |
| 52 Week High | CA$0.58 |
| 52 Week Low | CA$0.17 |
| Beta | 0.48 |
| 1 Month Change | -19.05% |
| 3 Month Change | n/a |
| 1 Year Change | -66.00% |
| 3 Year Change | -81.72% |
| 5 Year Change | -26.09% |
| Change since IPO | -83.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| MNX | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | -2.1% |
| 1Y | -66.0% | -1.3% | 3.6% |
Return vs Industry: MNX underperformed the Canadian Healthcare industry which returned 0.8% over the past year.
Return vs Market: MNX underperformed the Canadian Market which returned 3.2% over the past year.
Price Volatility
| MNX volatility | |
|---|---|
| MNX Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: MNX's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MNX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Steve Saviuk | n/a |
Manitex Capital Inc. focuses on acquiring interests in life sciences, cleantech, and sustainable products/technologies companies. It also holds a portfolio of marketable securities. Manitex Capital Inc. is headquartered in Kirkland, Canada.
Manitex Capital Inc. Fundamentals Summary
| MNX fundamental statistics | |
|---|---|
| Market cap | CA$2.15m |
| Earnings (TTM) | CA$838.02k |
| Revenue (TTM) | n/a |
2.6x
P/E Ratio0.0x
P/S RatioIs MNX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MNX income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | -CA$838.02k |
| Earnings | CA$838.02k |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.066 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 2.7% |
How did MNX perform over the long term?
See historical performance and comparison